Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
Clinical trial NCT00545948 · TERMINATED
Trial details
- NCT number
- NCT00545948
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2012-01-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.